eli lilly weight loss drug mounjaro

Eli Lilly, weight loss and Zepbound and Mounjaro

Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says

(Reuters) -Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, Brazil and Mexico by 2026, Chief Financial Officer Lucas Montarce said on Monday.

Devdiscourse · 4d

Eli Lilly's Global Expansion Plan for Blockbuster Drug Mounjaro

Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, and Mexico by 2025. With 900 million potential patients, the company aims to meet growing global demand alongside competitor Novo Nordisk.

KDVR & KWGN on MSN · 7d

Judge stops compounded copies of weight loss, diabetes drugs Zepbound, Mounjaro

A federal judge ended compounding pharmacies’ ability to make copies of the weight loss and diabetes drugs Zepbound and Mounjaro.

Reuters on MSN · 7d

US judge denies injunction, restricting copies of Lilly weight-loss drug

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and diabetes drugs Zepbound and Mounjaro in the United States.

STAT · 3d

Pharmalittle: We’re reading about Lilly and Roche weight loss drugs, FDA and compounders, and more

Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers

Weight Loss, Food and Drug Administration

USA TODAY on MSN · 10d

These discounted versions of popular weight-loss drugs are going away: What to know

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.

ABC News · 2d

Compound versions of some weight loss drugs to be restricted

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.

The New York Times · 18h

How Much Should Weight Loss Drugs Cost?

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.

The Hill8d

Federal judge stops compounded copies of Eli Lilly weight loss, diabetes drugs

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed ...

9don MSN

Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Devdiscourse4d

Eli Lilly Expands Global Reach with Mounjaro

Eli Lilly plans to globally launch its diabetes and weight-loss drug, Mounjaro, in countries including China, India, Brazil, ...

4don MSN

Is Eli Lilly Stock a Buy?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly plans to launch weight-loss drug in emerging markets this year

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results